Emerging literature suggests that like their ability to reduce desire for food, GLP-1 agonists can also reduce desire for other hedonistic pleasures such as cannabis [13,14], cigarettes [13], alcohol [13], opiates [15,16], and sexual desire [17] in patients with obesity or diabetes. The gene discussed is GLP1R; the disease is Obesity.